249 related articles for article (PubMed ID: 18460029)
1. Fluorescence lifetime imaging distinguishes basal cell carcinoma from surrounding uninvolved skin.
Galletly NP; McGinty J; Dunsby C; Teixeira F; Requejo-Isidro J; Munro I; Elson DS; Neil MA; Chu AC; French PM; Stamp GW
Br J Dermatol; 2008 Jul; 159(1):152-61. PubMed ID: 18460029
[TBL] [Abstract][Full Text] [Related]
2. Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics.
Seidenari S; Arginelli F; Dunsby C; French P; König K; Magnoni C; Manfredini M; Talbot C; Ponti G
Exp Dermatol; 2012 Nov; 21(11):831-6. PubMed ID: 22882324
[TBL] [Abstract][Full Text] [Related]
3. Laser-induced fluorescence and reflectance spectroscopy for the discrimination of basal cell carcinoma from the surrounding normal skin tissue.
Drakaki E; Kaselouris E; Makropoulou M; Serafetinides AA; Tsenga A; Stratigos AJ; Katsambas AD; Antoniou C
Skin Pharmacol Physiol; 2009; 22(3):158-65. PubMed ID: 19365155
[TBL] [Abstract][Full Text] [Related]
4. Combined non-linear laser imaging (two-photon excitation fluorescence microscopy, fluorescence lifetime imaging microscopy, multispectral multiphoton microscopy) in cutaneous tumours: first experiences.
De Giorgi V; Massi D; Sestini S; Cicchi R; Pavone FS; Lotti T
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):314-6. PubMed ID: 19207664
[TBL] [Abstract][Full Text] [Related]
5. Terahertz pulsed imaging of basal cell carcinoma ex vivo and in vivo.
Wallace VP; Fitzgerald AJ; Shankar S; Flanagan N; Pye R; Cluff J; Arnone DD
Br J Dermatol; 2004 Aug; 151(2):424-32. PubMed ID: 15327550
[TBL] [Abstract][Full Text] [Related]
6. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
[TBL] [Abstract][Full Text] [Related]
7. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.
Stenquist B; Ericson MB; Strandeberg C; Mölne L; Rosén A; Larkö O; Wennberg AM
Br J Dermatol; 2006 Feb; 154(2):305-9. PubMed ID: 16433801
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence lifetime imaging of unstained tissues: early results in human breast cancer.
Tadrous PJ; Siegel J; French PM; Shousha S; Lalani el-N; Stamp GW
J Pathol; 2003 Mar; 199(3):309-17. PubMed ID: 12579532
[TBL] [Abstract][Full Text] [Related]
9. Nonlinear laser imaging of skin lesions.
Cicchi R; Sestini S; De Giorgi V; Massi D; Lotti T; Pavone FS
J Biophotonics; 2008 Mar; 1(1):62-73. PubMed ID: 19343636
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of fluorescence diagnosis of basal cell carcinoma using a digital flash light-based imaging system.
Gambichler T; Moussa G; Altmeyer P
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):67-71. PubMed ID: 18353085
[TBL] [Abstract][Full Text] [Related]
11. Towards metabolic mapping of the human retina.
Schweitzer D; Schenke S; Hammer M; Schweitzer F; Jentsch S; Birckner E; Becker W; Bergmann A
Microsc Res Tech; 2007 May; 70(5):410-9. PubMed ID: 17393496
[TBL] [Abstract][Full Text] [Related]
12. Biochemical imaging of human atherosclerotic plaques with fluorescence lifetime angioscopy.
Thomas P; Pande P; Clubb F; Adame J; Jo JA
Photochem Photobiol; 2010; 86(3):727-31. PubMed ID: 20331523
[TBL] [Abstract][Full Text] [Related]
13. Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers.
Panjehpour M; Julius CE; Phan MN; Vo-Dinh T; Overholt S
Lasers Surg Med; 2002; 31(5):367-73. PubMed ID: 12430156
[TBL] [Abstract][Full Text] [Related]
14. Can autofluorescence demarcate basal cell carcinoma from normal skin? A comparison with protoporphyrin IX fluorescence.
Na R; Stender IM; Wulf HC
Acta Derm Venereol; 2001; 81(4):246-9. PubMed ID: 11720169
[TBL] [Abstract][Full Text] [Related]
15. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
16. In vivo optical coherence tomography of basal cell carcinoma.
Gambichler T; Orlikov A; Vasa R; Moussa G; Hoffmann K; Stücker M; Altmeyer P; Bechara FG
J Dermatol Sci; 2007 Mar; 45(3):167-73. PubMed ID: 17215110
[TBL] [Abstract][Full Text] [Related]
17. No clinical benefit of preoperative fluorescence diagnosis of basal cell carcinoma localized in the H-zone of the face.
Wetzig T; Kendler M; Maschke J; Paasch U; Simon JC
Br J Dermatol; 2010 Jun; 162(6):1370-6. PubMed ID: 20302577
[TBL] [Abstract][Full Text] [Related]
18. Reflectance confocal microscopy of pigmented basal cell carcinoma.
Agero AL; Busam KJ; Benvenuto-Andrade C; Scope A; Gill M; Marghoob AA; González S; Halpern AC
J Am Acad Dermatol; 2006 Apr; 54(4):638-43. PubMed ID: 16546585
[TBL] [Abstract][Full Text] [Related]
19. Two-photon lifetime imaging of fluorescent probes in intact blood vessels: a window to sub-cellular structural information and binding status.
Douma K; Megens RT; Reitsma S; Prinzen L; Slaaf DW; Van Zandvoort MA
Microsc Res Tech; 2007 May; 70(5):467-75. PubMed ID: 17393531
[TBL] [Abstract][Full Text] [Related]
20. Difficult to diagnose skin cancer--the 'aggressive' BCC.
Tomas S
Aust Fam Physician; 2009 Jul; 38(7):492-7. PubMed ID: 19575067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
